HIV suppression by host restriction factors and viral immune evasion

Current Opinion in Structural Biology

Volumn 31, Issue , 2015, Pages 106-114

  Jia, Xiaofei ^a   Zhao, Qi ^a   Xiong, Yong ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; BONE MARROW STROMAL CELL ANTIGEN 2; MYXOVIRUS RESISTANCE PROTEIN 2; PROTEIN SAMHD1; TRIPARTITE MOTIF PROTEIN 5; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

BIOCHEMICAL COMPOSITION; CRYSTAL STRUCTURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE EVASION; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; REVIEW; STRUCTURE ANALYSIS; TRANSCRIPTION REGULATION; VIRUS CAPSID; VIRUS ENVELOPE; VIRUS INHIBITION; ANIMAL; GENETICS; MUTATION; PHYSIOLOGY;

HUMAN IMMUNODEFICIENCY VIRUS;

ANIMALS; DNA, VIRAL; HIV; HUMANS; IMMUNE EVASION; MUTATION; REVERSE TRANSCRIPTION;

EID: 84937214129     PISSN: 0959440X     EISSN: 1879033X     Source Type: Journal    
DOI: 10.1016/j.sbi.2015.04.004     Document Type: Review

References (59)

1. Sayah D.M., Sokolskaja E., Berthoux L., Luban J. Cyclophilin a retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature 2004, 430:569-573.
2. Stremlau M., Owens C.M., Perron M.J., Kiessling M., Autissier P., Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in old world monkeys. Nature 2004, 427:848-853.
3. Stremlau M., Perron M., Lee M., Li Y., Song B., Javanbakht H., Diaz-Griffero F., Anderson D.J., Sundquist W.I., Sodroski J. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc Natl Acad Sci U S A 2006, 103:5514-5519.
4. Zhao G., Ke D., Vu T., Ahn J., Shah V.B., Yang R., Aiken C., Charlton L.M., Gronenborn A.M., Zhang P. Rhesus TRIM5alpha disrupts the HIV-1 capsid at the inter-hexamer interfaces. PLoS Pathog 2011, 7:e1002009.
5. Biris N., Yang Y., Taylor A.B., Tomashevski A., Guo M., Hart P.J., Diaz-Griffero F., Ivanov D.N. Structure of the rhesus monkey TRIM5alpha pryspry domain, the HIV capsid recognition module. Proc Natl Acad Sci U S A 2012, 109:13278-13283.
6. Yang H., Ji X., Zhao G., Ning J., Zhao Q., Aiken C., Gronenborn A.M., Zhang P., Xiong Y. Structural insight into HIV-1 capsid recognition by rhesus TRIM5alpha. Proc Natl Acad Sci U S A 2012, 109:18372-18377.
7. Li Y., Li X., Stremlau M., Lee M., Sodroski J. Removal of arginine 332 allows human TRIM5alpha to bind human immunodeficiency virus capsids and to restrict infection. J Virol 2006, 80:6738-6744.
8. Stremlau M., Perron M., Welikala S., Sodroski J. Species-specific variation in the b30.2(spry) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction. J Virol 2005, 79:3139-3145.
9. Yap M.W., Nisole S., Stoye J.P. A single amino acid change in the spry domain of human TRIM5alpha leads to HIV-1 restriction. Curr Biol 2005, 15:73-78.
10. Ganser-Pornillos B.K., Chandrasekaran V., Pornillos O., Sodroski J.G., Sundquist W.I., Yeager M. Hexagonal assembly of a restricting TRIM5alpha protein. Proc Natl Acad Sci U S A 2011, 108:534-539.
11. Goldstone D.C., Walker P.A., Calder L.J., Coombs P.J., Kirkpatrick J., Ball N.J., Hilditch L., Yap M.W., Rosenthal P.B., Stoye J.P., Taylor I.A. Structural studies of postentry restriction factors reveal antiparallel dimers that enable avid binding to the HIV-1 capsid lattice. Proc Natl Acad Sci U S A 2014, 111:9609-9614.
12. Sanchez J.G., Okreglicka K., Chandrasekaran V., Welker J.M., Sundquist W.I., Pornillos O. The tripartite motif coiled-coil is an elongated antiparallel hairpin dimer. Proc Natl Acad Sci U S A 2014, 111:2494-2499.
13. Goujon C., Moncorge O., Bauby H., Doyle T., Ward C.C., Schaller T., Hue S., Barclay W.S., Schulz R., Malim M.H. Human Mx2 is an interferon-induced post-entry inhibitor of HIV-1 infection. Nature 2013, 502:559-562.
14. Kane M., Yadav S.S., Bitzegeio J., Kutluay S.B., Zang T., Wilson S.J., Schoggins J.W., Rice C.M., Yamashita M., Hatziioannou T., Bieniasz P.D. Mx2 is an interferon-induced inhibitor of HIV-1 infection. Nature 2013, 502:563-566.
15. Liu Z., Pan Q., Ding S., Qian J., Xu F., Zhou J., Cen S., Guo F., Liang C. The interferon-inducible MxB protein inhibits HIV-1 infection. Cell Host Microbe 2013, 14:398-410.
16. Busnadiego I., Kane M., Rihn S.J., Preugschas H.F., Hughes J., Blanco-Melo D., Strouvelle V.P., Zang T.M., Willett B.J., Boutell C., Bieniasz P.D., et al. Host and viral determinants of Mx2 antiretroviral activity. J Virol 2014, 88:7738-7752.
17. Goujon C., Moncorge O., Bauby H., Doyle T., Barclay W.S., Malim M.H. Transfer of the amino-terminal nuclear envelope targeting domain of human Mx2 converts Mx1 into an HIV-1 resistance factor. J Virol 2014, 88:9017-9026.
18. Fribourgh J.L., Nguyen H.C., Matreyek K.A., Alvarez F.J., Summers B.J., Dewdney T.G., Aiken C., Zhang P., Engelman A., Xiong Y. Structural insight into HIV-1 restriction by MxB. Cell Host Microbe 2014, 16:627-638.
19. Sheehy A.M., Gaddis N.C., Choi J.D., Malim M.H. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 2002, 418:646-650.
20. Harris R.S., Bishop K.N., Sheehy A.M., Craig H.M., Petersen-Mahrt S.K., Watt I.N., Neuberger M.S., Malim M.H. DNA deamination mediates innate immunity to retroviral infection. Cell 2003, 113:803-809.
21. Zhang H., Yang B., Pomerantz R.J., Zhang C., Arunachalam S.C., Gao L. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 2003, 424:94-98.
22. Bishop K.N., Verma M., Kim E.Y., Wolinsky S.M., Malim M.H. APOBEC3G inhibits elongation of HIV-1 reverse transcripts. PLoS Pathog 2008, 4:e1000231.
23. Iwatani Y., Chan D.S., Wang F., Maynard K.S., Sugiura W., Gronenborn A.M., Rouzina I., Williams M.C., Musier-Forsyth K., Levin J.G. Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G. Nucleic Acids Res 2007, 35:7096-7108.
24. Yu X., Yu Y., Liu B., Luo K., Kong W., Mao P., Yu X.F. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 2003, 302:1056-1060.
25. Aydin H., Taylor M.W., Lee J.E. Structure-guided analysis of the human APOBEC3-HIV restrictome. Structure 2014, 22:668-684.
26. Guo Y., Dong L., Qiu X., Wang Y., Zhang B., Liu H., Yu Y., Zang Y., Yang M., Huang Z. Structural basis for hijacking CBF-beta and Cul5 E3 ligase complex by HIV-1 Vif. Nature 2014, 505:229-233.
27. Fribourgh J.L., Nguyen H.C., Wolfe L.S., Dewitt D.C., Zhang W., Yu X.F., Rhoades E., Xiong Y. Core binding factor beta plays a critical role by facilitating the assembly of the Vif-cullin 5 E3 ubiquitin ligase. J Virol 2014, 88:3309-3319.
28. Hrecka K., Hao C., Gierszewska M., Swanson S.K., Kesik-Brodacka M., Srivastava S., Florens L., Washburn M.P., Skowronski J. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 2011, 474:658-661.
29. Berger A., Sommer A.F., Zwarg J., Hamdorf M., Welzel K., Esly N., Panitz S., Reuter A., Ramos I., Jatiani A., Mulder L.C., et al. SAMHD1-deficient CD14+ cells from individuals with Aicardi-Goutieres syndrome are highly susceptible to HIV-1 infection. PLoS Pathog 2011, 7:e1002425.
30. Goldstone D.C., Ennis-Adeniran V., Hedden J.J., Groom H.C., Rice G.I., Christodoulou E., Walker P.A., Kelly G., Haire L.F., Yap M.W., de Carvalho L.P., et al. HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature 2011, 480:379-382.
31. Franzolin E., Pontarin G., Rampazzo C., Miazzi C., Ferraro P., Palumbo E., Reichard P., Bianchi V. The deoxynucleotide triphosphohydrolase SAMHD1 is a major regulator of DNA precursor pools in mammalian cells. Proc Natl Acad Sci U S A 2013, 110:14272-14277.
32. White TommyF E., Brandariz-Nuñez A., Valle-Casuso JoseF C., Amie S., Nguyen LauraA, Kim B., Tuzova M., Diaz-Griffero F. The retroviral restriction ability of SAMHD1, but not its deoxynucleotide triphosphohydrolase activity, is regulated by phosphorylation. Cell Host Microbe 2013, 13:441-451.
33. Kretschmer S., Wolf C., König N., Staroske W., Guck J., Häusler M., Luksch H., Nguyen L.A., Kim B., Alexopoulou D., Dahl A., et al. SAMHD1 prevents autoimmunity by maintaining genome stability. Ann Rheum Dis 2014, 74:e17.
34. Clifford R., Louis T., Robbe P., Ackroyd S., Burns A., Timbs A.T., Wright Colopy G., Dreau H., Sigaux F., Judde J.G., Rotger M., et al. SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage. Blood 2014, 123:1021-1031.
35. Ji X., Wu Y., Yan J., Mehrens J., Yang H., DeLucia M., Hao C., Gronenborn A.M., Skowronski J., Ahn J., Xiong Y. Mechanism of allosteric activation of SAMHD1 by dGTP. Nat Struct Mol Biol 2013, 20:1304-1309.
36. Zhu C., Gao W., Zhao K., Qin X., Zhang Y., Peng X., Zhang L., Dong Y., Zhang W., Li P., Wei W., et al. Structural insight into dGTP-dependent activation of tetrameric SAMHD1 deoxynucleoside triphosphate triphosphohydrolase. Nat Commun 2013, 4:2722.
37. Ji X., Tang C., Zhao Q., Wang W., Xiong Y. Structural basis of cellular dNTP regulation by SAMHD1. Proc Natl Acad Sci U S A 2014, 111:E4305-E4314.
38. Koharudin L.M., Wu Y., DeLucia M., Mehrens J., Gronenborn A.M., Ahn J. Structural basis of allosteric activation of sterile alpha motif and histidine-aspartate domain-containing protein 1 (SAMHD1) by nucleoside triphosphates. J Biol Chem 2014, 289:32617-32627.
39. Ahn J., Hao C., Yan J., DeLucia M., Mehrens J., Wang C., Gronenborn A.M., Skowronski J. Hiv/simian immunodeficiency virus (SIV) accessory virulence factor vpx loads the host cell restriction factor SAMHD1 onto the E3 ubiquitin ligase complex CRL4DCAF1. J Biol Chem 2012, 287:12550-12558.
40. Lim E.S., Fregoso O.I., McCoy C.O., Matsen F.A., Malik H.S., Emerman M. The ability of primate lentiviruses to degrade the monocyte restriction factor SAMHD1 preceded the birth of the viral accessory protein Vpx. Cell Host Microbe 2012, 11:194-204.
41. Fregoso O.I., Ahn J., Wang C., Mehrens J., Skowronski J., Emerman M. Evolutionary toggling of Vpx/Vpr specificity results in divergent recognition of the restriction factor SAMHD1. PLoS Pathog 2013, 9:e1003496.
42. Schwefel D., Groom H.C., Boucherit V.C., Christodoulou E., Walker P.A., Stoye J.P., Bishop K.N., Taylor I.A. Structural basis of lentiviral subversion of a cellular protein degradation pathway. Nature 2014, 505:234-238.
43. Schwefel D., Boucherit V.C., Christodoulou E., Walker P.A., Stoye J.P., Bishop K.N., Taylor I.A. Molecular determinants for recognition of divergent SAMHD1 proteins by the lentiviral accessory protein Vpx. Cell Host Microbe 2015, 17:489-499. 10.1016/j.chom.2015.03.004.
44. Beloglazova N., Flick R., Tchigvintsev A., Brown G., Popovic A., Nocek B., Yakunin A.F. Nuclease activity of the human SAMHD1 protein implicated in the Aicardi-Goutieres syndrome and HIV-1 restriction. J Biol Chem 2013, 288:8101-8110.
45. Goncalves A., Karayel E., Rice G.I., Bennett K.L., Crow Y.J., Superti-Furga G., Burckstummer T. SAMHD1 is a nucleic-acid binding protein that is mislocalized due to Aicardi-Goutieres syndrome-associated mutations. Hum Mutat 2012, 33:1116-1122.
46. White T.E., Brandariz-Nunez A., Carlos Valle-Casuso J., Amie S., Nguyen L., Kim B., Brojatsch J., Diaz-Griffero F. Contribution of SAM and HD domains to retroviral restriction mediated by human SAMHD1. Virology 2012, 436:81-90.
47. Ryoo J., Choi J., Oh C., Kim S., Seo M., Kim S.Y., Seo D., Kim J., White T.E., Brandariz-Nunez A., Diaz-Griffero F., et al. The ribonuclease activity of SAMHD1 is required for HIV-1 restriction. Nat Med 2014, 20:936-941.
48. Neil S.J., Zang T., Bieniasz P.D. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 2008, 451:425-430.
49. Van Damme N., Goff D., Katsura C., Jorgenson R.L., Mitchell R., Johnson M.C., Stephens E.B., Guatelli J. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 2008, 3:245-252.
50. Galao R.P., Le Tortorec A., Pickering S., Kueck T., Neil S.J. Innate sensing of HIV-1 assembly by tetherin induces NFkappaB-dependent proinflammatory responses. Cell Host Microbe 2012, 12:633-644.
51. Tokarev A., Suarez M., Kwan W., Fitzpatrick K., Singh R., Guatelli J. Stimulation of NF-kappaB activity by the HIV restriction factor BST2. J Virol 2013, 87:2046-2057.
52. Hinz A., Miguet N., Natrajan G., Usami Y., Yamanaka H., Renesto P., Hartlieb B., McCarthy A.A., Simorre J.P., Gottlinger H., Weissenhorn W. Structural basis of HIV-1 tethering to membranes by the BST-2/tetherin ectodomain. Cell Host Microbe 2010, 7:314-323.
53. Schubert H.L., Zhai Q., Sandrin V., Eckert D.M., Garcia-Maya M., Saul L., Sundquist W.I., Steiner R.A., Hill C.P. Structural and functional studies on the extracellular domain of BST2/tetherin in reduced and oxidized conformations. Proc Natl Acad Sci U S A 2010, 107:17951-17956.
54. Swiecki M., Scheaffer S.M., Allaire M., Fremont D.H., Colonna M., Brett T.J. Structural and biophysical analysis of BST-2/tetherin ectodomains reveals an evolutionary conserved design to inhibit virus release. J Biol Chem 2011, 286:2987-2997.
55. Yang H., Wang J., Jia X., McNatt M.W., Zang T., Pan B., Meng W., Wang H.W., Bieniasz P.D., Xiong Y. Structural insight into the mechanisms of enveloped virus tethering by tetherin. Proc Natl Acad Sci U S A 2010, 107:18428-18432.
56. Venkatesh S., Bieniasz P.D. Mechanism of HIV-1 virion entrapment by tetherin. PLoS Pathog 2013, 9:e1003483.
57. Sauter D. Counteraction of the multifunctional restriction factor tetherin. Front Microbiol 2014, 5:163.
58. Bartee E., McCormack A., Fruh K. Quantitative membrane proteomics reveals new cellular targets of viral immune modulators. PLoS Pathog 2006, 2:975-988.
59. Jia X., Weber E., Tokarev A., Lewinski M., Rizk M., Suarez M., Guatelli J., Xiong Y. Structural basis of HIV-1 Vpu-mediated BST2 antagonism via hijacking of the clathrin adaptor protein complex 1. eLife 2014, 3:e02362.